VIM and cancer: Therefore, while other groups have found that vimentin deficiency impairs function in cancer-associated fibroblasts and immune cells such as macrophages and T cells [56, 58, 65, 70], a vimentin-expressing microenvironment is not sufficient to promote metastasis in the time frame evaluated.